Frankfurt - Delayed Quote EUR

Xenon Pharmaceuticals Inc. (XP0.F)

26.20
-0.20
(-0.76%)
As of 8:02:54 AM GMT+2. Market Open.

Research Analysis

Revenue vs. Earnings

Revenue 7.5M
Earnings -65.05M

Q2'24

Q3'24

Q4'24

Q1'25

-60M
-40M
-20M
0
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 15151716
Avg. Estimate ----7.38M20.78M
Low Estimate ----5M--
High Estimate ----8M200M
Year Ago Sales ------7.38M
Sales Growth (year/est) 0.00%0.00%0.00%181.55%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
XP0.F --------
S&P 500 13.17%2.85%7.92%13.78%

Upgrades & Downgrades

Initiated Evercore ISI Group: Outperform 5/14/2025
Maintains Wells Fargo: Overweight to Overweight 5/13/2025
Maintains RBC Capital: Outperform to Outperform 5/13/2025
Reiterates HC Wainwright & Co.: Buy to Buy 5/13/2025
Maintains Needham: Buy to Buy 5/13/2025
Maintains Chardan Capital: Buy to Buy 5/13/2025

Related Tickers